KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally

Nov.06.2025
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.

2Firsts, November 6, 2025 — Korean tobacco giant KT&G released its financial results for the third quarter of 2025, reporting significant growth across key performance indicators and achieving its highest operating profit in five years.

 

Key Financial Highlights

 

  • Revenue: KRW 1.83 trillion (≈USD 1.31 billion), up 11.6% year-over-year
  • Operating Profit: KRW 465.3 billion (≈USD 332 million), up 11.4%, marking a five-year high
  • Net Profit: KRW 418.7 billion (≈USD 299 million), up 73.4% year-over-year
  • Earnings per Share (EPS): KRW 3,898 (≈USD 2.78)

 

Next Generation Product (NGP) Performance

 

Growth in the NGP segment was driven by expanded device and consumable product lines in both domestic and overseas markets, as well as the fulfillment of backlogged device orders from the first half of the year.

 

  • Total NGP Revenue: KRW 279.1 billion (≈USD 199 million), up from KRW 193.2 billion (≈USD 138 million) in Q3 2024
  • Overseas NGP Revenue: KRW 110.8 billion (≈USD 79 million), up from KRW 36.6 billion (≈USD 26 million) in Q3 2024
  • Domestic NGP Revenue: KRW 168.3 billion (≈USD 120 million)
  • Sales Drivers: The launch of the upgraded lil SOLID device in Russia and the resumption of delayed shipments led to a 13.3% year-over-year increase in consumable sales.

 

Strategic Partnership & Nicotine Pouch Expansion

 

  • Strategic Partnership: KT&G announced a partnership with Altria to jointly acquire Nordic nicotine pouch manufacturer ASF.
  • Global Expansion Plan: Starting in 2026, KT&G aims to expand its nicotine pouch business from five Nordic markets to Europe, the Middle East, Africa, Asia, and North America.
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
According to public records from China’s National Intellectual Property Administration, a patent application filed by China Tobacco Yunnan Industrial Co., Ltd. for “cigar flavor granules” was published on May 12, 2026. The filing proposes purifying an ethanol extract of cigar tobacco leaves using LX-8 macroporous resin, followed by encapsulation with maltodextrin and sucrose fatty acid ester to improve smoking comfort, reduce dryness and enhance aroma release stability in reconstituted tobacco.
Jun.10
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has stopped using Webloc, a commercial phone-tracking tool, after lawmakers, a prosecutor and a judge raised legal and privacy concerns over warrantless use of ad-tech location data, a development that may affect data-use boundaries in U.S. enforcement against illicit tobacco, nicotine products and cross-border distribution networks.
Jun.29
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16